Alpha Teknova Share Price (NASDAQ: TKNO)

$4.33

▲

0.02

(0.46%)

Live

Last updated on August 30, 2025 at 12:30 am IST

$₹

Check the interactive Alpha Teknova Stock chart to analyse performance

Alpha Teknova stock performance

as on August 30, 2025 at 12:30 am IST

Today's Low:$4.27
Today's High:$4.33
$4.33
1.5%
Downside
Day's Volatility :1.5%
Upside
0.0%
52 Weeks Low:$4.00
52 Weeks High:$10.37
$4.33
7.62%
Downside
52 Weeks Volatility :61.43%
Upside
58.24%

Alpha Teknova Stock Returns

Period	Alpha Teknova Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-25.3%	3.1%	0.0%
6 Months	-33.69%	-8.4%	0.0%
1 Year	-8.3%	-12.6%	0.0%
3 Years	-9.64%	7.9%	-6.1%

Alpha Teknova Inc Key Stats

Check Alpha Teknova key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.31
Open	$4.45
Today's High	$4.38
Today's Low	$4.265
Market Capitalization	$238.1M
Today's Volume	$272.8K
52 Week High	$10.37
52 Week Low	$4.0
Revenue TTM	$38.9M
EBITDA	$-14.8M
Earnings Per Share (EPS)	$-0.39
Profit Margin	-55.24%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-27.74%

Stock Returns calculator for Alpha Teknova Stock including INR - Dollar returns

The Alpha Teknova stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alpha Teknova investment value today

Current value as on today

₹97,305

Returns

₹2,695

(-2.7%)

Returns from Alpha Teknova Stock

₹7,872 (-7.87%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Alpha Teknova Stock

-47%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Alpha Teknova Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Alpha Teknova Inc

Name
Holdings %
Name
Holdings %
UBS Group AG
2.17%
Balyasny Asset Management LLC
1.56%
Vanguard Group Inc
1.22%
Roubaix Capital, LLC
0.82%
CenterBook Partners LP
0.58%
Goldman Sachs Group Inc
0.51%

Analyst Recommendation on Alpha Teknova Stock

Rating

Trend

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Alpha Teknova(by analysts ranked 0 to 5 stars)

Alpha Teknova Share Price Target

What analysts predicted

Upside of 130.95%

Target:

$10.00

Current:

$4.33

Alpha Teknova share price target is $10.00, a slight Upside of 130.95% compared to current price of $4.33 as per analysts' prediction.

Alpha Teknova Stock Insights

Price Movement
In the last 7 days, TKNO stock has moved down by -9.3%
Increasing Revenue
Revenue is up for the last 3 quarters, 9.26M → 10.28M (in $), with an average increase of 5.1% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -7.56M → -3.57M (in $), with an average increase of 28.5% per quarter
TKNO vs NBIX (1 yr)
In the last 1 year, Neurocrine Biosciences Inc. has given 8.2% return, outperforming this stock by 16.5%
TKNO vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 31.9% return, outperforming this stock by 40.6%
Price to Sales
ForTKNO every $1 of sales, investors are willing to pay $5.9, whereas for Neurocrine Biosciences Inc., the investors are paying $5.5 for every $1 of sales.

Alpha Teknova Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$20.1M	-
Net Income	$-1.3M	-
Net Profit Margin	-6.49%	-

	FY20	Y/Y Change
Revenue	$31.3M	↑ 55.75%
Net Income	$3.6M	↓ 373.56%
Net Profit Margin	11.41%	↑ 17.9%

	FY21	Y/Y Change
Revenue	$36.9M	↑ 17.88%
Net Income	$-9.8M	↓ 374.59%
Net Profit Margin	-26.57%	↓ 37.98%

	FY22	Y/Y Change
Revenue	$41.4M	↑ 12.27%
Net Income	$-47.5M	↑ 384.22%
Net Profit Margin	-114.6%	↓ 88.03%

	FY23	Y/Y Change
Revenue	$36.7M	↓ 11.43%
Net Income	$-36.8M	↓ 22.52%
Net Profit Margin	-100.26%	↑ 14.34%

	FY24	Y/Y Change
Revenue	$37.7M	↑ 2.89%
Net Income	$-26.7M	↓ 27.28%
Net Profit Margin	-70.86%	↑ 29.4%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$9.3M	↑ 18.09%
Net Income	$-8.1M	↓ 24.01%
Net Profit Margin	-87.16%	↑ 48.29%

	Q2 FY24	Q/Q Change
Revenue	$9.6M	↑ 3.49%
Net Income	$-5.4M	↓ 33.75%
Net Profit Margin	-55.79%	↑ 31.37%

	Q3 FY24	Q/Q Change
Revenue	$9.6M	↓ 0.4%
Net Income	$-7.6M	↑ 41.03%
Net Profit Margin	-79.0%	↓ 23.21%

	Q4 FY24	Q/Q Change
Revenue	$9.3M	↓ 3.25%
Net Income	$-5.7M	↓ 24.4%
Net Profit Margin	-61.73%	↑ 17.27%

	Q1 FY25	Q/Q Change
Revenue	$9.8M	↑ 5.72%
Net Income	$-4.6M	↓ 18.78%
Net Profit Margin	-47.42%	↑ 14.31%

	Q2 FY25	Q/Q Change
Revenue	$10.3M	↑ 5.02%
Net Income	$-3.6M	↓ 23.14%
Net Profit Margin	-34.7%	↑ 12.72%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$8.6M	-

	FY20	Y/Y Change
Profit	$17.8M	↑ 107.08%

	FY21	Y/Y Change
Profit	$17.6M	↓ 0.75%

	FY22	Y/Y Change
Profit	$17.5M	↓ 0.82%

	FY23	Y/Y Change
Profit	$10.3M	↓ 41.08%

	FY24	Y/Y Change
Profit	$7.2M	↓ 29.77%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 65.47%

	Q2 FY24	Q/Q Change
Profit	$2.8M	↑ 26.94%

	Q3 FY24	Q/Q Change
Profit	$90.0K	↓ 96.79%

	Q4 FY24	Q/Q Change
Profit	$2.1M	↑ 2264.44%

	Q1 FY25	Q/Q Change
Profit	$3.0M	↑ 41.31%

	Q2 FY25	Q/Q Change
Profit	$4.0M	↑ 32.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$2.2M	-
Investing Cash Flow	$-8.2M	-
Financing Cash Flow	$8.6M	-

	FY20	Y/Y Change
Operating Cash Flow	$2.5M	↑ 15.33%
Investing Cash Flow	$-1.7M	↓ 78.73%
Financing Cash Flow	$-1.6M	↓ 118.66%

	FY21	Y/Y Change
Operating Cash Flow	$-9.1M	↓ 462.04%
Investing Cash Flow	$-17.5M	↑ 909.86%
Financing Cash Flow	$110.8M	↓ 7028.89%

	FY22	Y/Y Change
Operating Cash Flow	$-27.4M	↑ 202.13%
Investing Cash Flow	$-28.1M	↑ 60.66%
Financing Cash Flow	$10.3M	↓ 90.73%

	FY23	Y/Y Change
Operating Cash Flow	$-18.8M	↓ 31.34%
Investing Cash Flow	$-7.7M	↓ 72.51%
Financing Cash Flow	$12.8M	↑ 24.66%

	FY24	Y/Y Change
Operating Cash Flow	$-12.4M	↓ 34.01%
Investing Cash Flow	$-27.3M	↑ 252.53%
Financing Cash Flow	$14.9M	↑ 16.34%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.6M	↑ 126.76%
Investing Cash Flow	$13.0K	↓ 111.3%
Financing Cash Flow	$-343.0K	↓ 44.77%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-2.8M	↓ 56.72%
Investing Cash Flow	$-115.0K	↓ 984.62%
Financing Cash Flow	$-47.0K	↓ 86.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 27.45%
Investing Cash Flow	$-25.8M	↑ 22299.13%
Financing Cash Flow	$15.4M	↓ 32795.74%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-936.0K	↓ 54.54%
Investing Cash Flow	$-1.4M	↓ 94.51%
Financing Cash Flow	$-87.0K	↓ 100.57%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.1M	↑ 338.35%
Investing Cash Flow	$3.8M	↓ 370.44%
Financing Cash Flow	$-52.0K	↓ 40.23%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-2.2M	↓ 46.36%
Investing Cash Flow	$2.0M	↓ 46.97%
Financing Cash Flow	$72.0K	↓ 238.46%

Alpha Teknova Technicals Summary

Sell

Neutral

Buy

Alpha Teknova is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Alpha Teknova Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alpha Teknova Inc	-10.95%	-33.69%	-8.3%	-9.64%	-81.87%
Haleon Plc Spon Ads	0.52%	-4.81%	-3.96%	59.37%	30.77%
United Therapeutics Corporation	8.95%	-4.02%	-14.72%	40.29%	72.75%
Zoetis Inc.	4.01%	-7.46%	-15.38%	-1.47%	-3.33%
Neurocrine Biosciences Inc.	1.61%	17.05%	8.2%	34.52%	19.36%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alpha Teknova Inc	NA	NA	NA	-0.34	-0.28	-0.12	NA	1.42
Haleon Plc Spon Ads	21.58	21.58	3.15	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.91	11.91	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.69	26.69	2.51	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.11	41.11	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alpha Teknova Inc	Buy	$238.1M	-81.87%	NA	-55.24%
Haleon Plc Spon Ads	Buy	$43.5B	30.77%	21.58	13.81%
United Therapeutics Corporation	Buy	$13.8B	72.75%	11.91	40.36%
Zoetis Inc.	Buy	$68.6B	-3.33%	26.69	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	19.36%	41.11	13.88%

About Alpha Teknova Inc

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Organization	Alpha Teknova
Employees	173
CEO	Mr. Stephen Gunstream
Industry	Healthcare

Key Management of Alpha Teknova Inc

Name	Title
Mr. Stephen Gunstream	President, CEO & Director
Mr. Matthew C. Lowell	Chief Financial Officer
Mr. Damon A. Terrill J.D.	General Counsel, Chief Compliance Officer & Secretary
Ms. Jennifer Henry	Senior Vice President of Marketing

Important FAQs about investing in TKNO Stock from India :

What is Alpha Teknova share price today?

Alpha Teknova share price today is $4.33 as on August 30, 2025 at 12:30 am IST. Alpha Teknova share today touched a day high of $4.33 and a low of $4.27.

What is the 52 week high and 52 week low for Alpha Teknova share?

Alpha Teknova share touched a 52 week high of $10.37 and a 52 week low of $4.00. Alpha Teknova stock price today i.e. August 30, 2025 at 12:30 am IST is trending at $4.33, lower by 58.24% versus the 52 week high.

How to invest in Alpha Teknova Stock (TKNO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alpha Teknova on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alpha Teknova Shares that will get you 0.3464 shares as per Alpha Teknova share price of $4.33 per share as on August 30, 2025 at 12:30 am IST.

What is the minimum amount required to buy Alpha Teknova Stock (TKNO) from India?

Indian investors can start investing in Alpha Teknova (TKNO) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Alpha Teknova stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Alpha Teknova share’s latest price of $4.33 as on August 30, 2025 at 12:30 am IST, you will get 2.3095 shares of Alpha Teknova. Learn more about fractional shares .

What are the returns that Alpha Teknova has given to Indian investors in the last 5 years?

Alpha Teknova stock has given -81.87% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?